Microbot Medical Receives a Non-Dilutive Grant from The Israel Innovation Authority Supporting the Development of the Manufacturing Process for its Endovascular Surgical Robotic System
Microbot Medical Inc. (MBOT)
Last microbot medical inc. earnings: 11/14 03:34 pm
Check Earnings Report
US:NASDAQ Investor Relations:
microbotmedical.com/investors
Company Research
Source: GlobeNewswire
HINGHAM, Mass., June 02, 2023 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), the developer of the LIBERTY® Robotic Surgical System, the first single-use endovascular robotic surgical system, announced it has received a grant from the Israel Innovation Authority ("IIA”) in the amount of NIS 1.62 million, which based on a recent exchange rate to the U.S. dollar, would be approximately $440,000, to further support the development of the Company’s manufacturing process of its flagship robotic surgical system, the LIBERTY®. This is the first time Microbot has received approval for a grant for "transition from development to manufacturing" program, which the Company believe is a reflection of the recent activities and milestones the LIBERTY achieved as it progresses in its path toward its regulatory and commercialization activities. “This non-dilutive grant will facilitate our efforts to establish the manufacturing infrastructure capability for the LIBERTY® system. While
Show less
Read more
Impact Snapshot
Event Time:
MBOT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
MBOT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
MBOT alerts
High impacting Microbot Medical Inc. news events
Weekly update
A roundup of the hottest topics
MBOT
News
- Microbot Medical Inc. (NASDAQ: MBOT) had its price target lowered by analysts at HC Wainwright from $8.00 to $7.00. They now have a "buy" rating on the stock.MarketBeat
- Microbot Medical Shares Status Following Recent Geopolitical Events [Yahoo! Finance]Yahoo! Finance
- Microbot Medical Shares Status Following Recent Geopolitical EventsGlobeNewswire
- Microbot Medical (MBOT) Files IDE to Start Human Clinical Study [Yahoo! Finance]Yahoo! Finance
- Microbot Medical Submits an IDE Application to Gain FDA Approval to Commence Its Pivotal Clinical Trial in the USGlobeNewswire
MBOT
Sec Filings
- 4/25/24 - Form 424B3
- 4/24/24 - Form 8-K
- 4/16/24 - Form 424B3
- MBOT's page on the SEC website